BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
D. А. Kuznetsova, S. V. Lapin, O. B. Shchukina. The diagnostic and prognostic value of serological markers of inflammatory bowel diseases (a literature review)Almanac of Clinical Medicine 2020; 48(6): 364 doi: 10.18786/2072-0505-2020-48-061
C. A. Siegel, H. Horton, L. S. Siegel, K. D. Thompson, T. Mackenzie, S. K. Stewart, P. W. Rice, J. M. Stempak, S. Dezfoli, T. Haritunians, A. Levy, M. Baek, R. Milgrom, P. S. Dulai, S. R. Targan, M. S. Silverberg, M. C. Dubinsky, D. P. McGovern. A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variablesAlimentary Pharmacology & Therapeutics 2016; 43(2): 262 doi: 10.1111/apt.13460
Samir Jawhara, Xavier Thuru, Annie Standaert‐Vitse, Thierry Jouault, Serge Mordon, Boualem Sendid, Pierre Desreumaux, Daniel Poulain. Colonization of Mice byCandida albicansIs Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3The Journal of Infectious Diseases 2008; 197(7): 972 doi: 10.1086/528990
Reinhold Ramoner, Andrea Rahm, Hubert Gander, Björn Stollenwerk, Claudia Falkensammer, Nicolai Leonhartsberger, Martin Thurnher. Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinomaCancer Immunology, Immunotherapy 2008; 57(8): 1207 doi: 10.1007/s00262-008-0454-0
Lani Prideaux, Peter De Cruz, Siew C. Ng, Michael A. Kamm. Serological Antibodies in Inflammatory Bowel Disease: A Systematic ReviewInflammatory Bowel Diseases 2012; 18(7): 1340 doi: 10.1002/ibd.21903
A. Eser, P. Papay, C. Primas, E. Pernicka, M. Harrer, C. Dejaco, G. Novacek, C. Lichtenberger, S. Angelberger, L. Kazemi, A. Mikulits, H. Vogelsang, W. Reinisch. The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s diseaseAlimentary Pharmacology & Therapeutics 2012; 35(2): 292 doi: 10.1111/j.1365-2036.2011.04932.x
Thomas Schaffer, Stefan Müller, Beatrice Flogerzi, Beatrice Seibold-Schmid, Alain M. Schoepfer, Frank Seibold. Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohnʼs patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicansInflammatory Bowel Diseases 2007; 13(11): 1339 doi: 10.1002/ibd.20228
Ole Høie, Geir Aamodt, Severine Vermeire, Tomm Bernklev, Selwyn Odes, Frank L. Wolters, Lene Riis, Patrizia Politi, Epameinondas V. Tsianos, Mercedes Butrón, Reinhold W. Stockbrügger, Pia Munkholm, Morten Vatn, Bjørn Moum. Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 yearsJournal of Crohn's and Colitis 2008; 2(2): 114 doi: 10.1016/j.crohns.2007.10.001
Annie Standaert-Vitse, Boualem Sendid, Marie Joossens, Nadine François, Peggy Vandewalle-El Khoury, Julien Branche, Herbert Van Kruiningen, Thierry Jouault, Paul Rutgeerts, Corinne Gower-Rousseau, Christian Libersa, Christel Neut, Franck Broly, Mathias Chamaillard, Séverine Vermeire, Daniel Poulain, Jean-Frédéric Colombel. Candida albicans Colonization and ASCA in Familial Crohn's DiseaseThe American Journal of Gastroenterology 2009; 104(7): 1745 doi: 10.1038/ajg.2009.225
Florian Rieder, Subra Kugathasan. Circulating Antibodies against Bacterial Wall Products: Are There Arguments for Early Immunosuppression?Digestive Diseases 2012; 30(s3): 55 doi: 10.1159/000342603
C. N. Bernstein, J. D. Ryan, L. A. Graff, W. Xu. Commentary: predicting complicated Crohn's disease and surgery - phenotypes, genetics, serology and psychological characteristics of a population-based cohort - authors’ replyAlimentary Pharmacology & Therapeutics 2013; 38(5): 556 doi: 10.1111/apt.12423